Plasma VEGF and Leptin Values in Patients With Gastric Intestinal Metaplasia and Metabolic Syndrome
Open Access
- 31 May 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 905168
Abstract
Intestinal metaplasia of the stomach (IM) is considered a pre-cancerous lesion and is a potential precursor to adenocarcinoma. Metabolic syndrome (MetS) has been associated with lesions to the gastrointestinal tract such as the risk of developing Barett esophagus. Vascular endothelial growth factor and leptin have been associated with either gastrointestinal tract carcinogenesis or MetS. In this context, this study was designed to analyze plasma levels of VEGF and leptin in patients with IM and MetS. Four groups of 137 participants (a control group and three patient groups, IM, MetS and IM- MetS) were created. Inclusion criteria for the presence of IM were endoscopic findings and histological confirmation, while for MetS the ATP III and IDF guidelines. Levels of plasma vascular endothelial growth factor (VEGF) and leptin (Leptin) were determined. VEGF levels were increased in IM (IM vs Control, p=0,011) and IM-MetS groups (IM-MetS vs Control, p <0.001 and IM-MetS vs MetS, p=0.001). Leptin levels were found to be increased in the MetS group (MetS vs. Control, p <0.001 and MetS vs IM, p <0.001) and in IM-MetS (IM-MetS vs Control, p = 0.002, IM-MetS vs IM, p=0.033). Patients with intestinal metaplasia and metabolic syndrome (I M - Me t S g r o u p) have elevated levels of VEGF, while leptin levels were associated predominantly with MetS and not with IM.Keywords
This publication has 42 references indexed in Scilit:
- Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardiaWorld Journal of Gastroenterology, 2012
- Chronic Inflammation in Obesity and the Metabolic SyndromeMediators of Inflammation, 2010
- Pathology of Gastric Intestinal Metaplasia: Clinical ImplicationsAmerican Journal of Gastroenterology, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Obesity and Cancer: The Role of Dysfunctional Adipose TissueCancer Epidemiology, Biomarkers & Prevention, 2009
- Low‐grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM studyEuropean Journal of Clinical Investigation, 2009
- Barrett EsophagusAnnals of Surgery, 2008
- Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Leptin: a review of its peripheral actions and interactionsInternational Journal of Obesity, 2002
- Recombinant Mouse OB Protein: Evidence for a Peripheral Signal Linking Adiposity and Central Neural NetworksScience, 1995